Effects of daglipzin on renal function and miR-21-5p and miR-423-5p levels in patients with diabetic nephropathy

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 8

Abstract

Objective</b>To analyze the effects of dapagliflozin on blood glucose levels, renal function, and the levels of miR-21-5p and miR-423-5p in patients with diabetic nephropathy. Methods A total of 98 patients with diabetic nephropathy admitted in The Second People's Hospital of Hefei from February 2022 to October 2023 were selected and divided into the control group (n=49) and the observation group (n=49) according to the random number table method. The control group was treated with metformin, and the observation group was treated with a combination of metformin and dapagliflozin. Blood glucose levels, renal function, expression levels of miR-21-5p, miR-423-5p and serum proinflammatory factors before and after treatment were compared between the two groups, and the incidence of adverse reactions was recorded. Results The levels of fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and serum creatinine (Scr), blood urea nitrogen (BUN), cystatin C (Cys-C) in both groups decreased after 3 months of treatment, and the above indexes in the observation group were lower than those in the control group (P<0.05). Similarly, levels of miR-21-5p, miR-423-5p, C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were significantly lower in the observation group compared to the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the observation group and the control group (12.24% vs6.12%, P>0.05). Conclusion Daglipzin can help improve the blood sugar level and renal function of patients with diabetes nephropathy, reduce the expression of miR-21-5p, miR-423-5p and the level of serum proinflammatory factors, with good safety.

Authors and Affiliations

MA Tingting*, LIU Li, XU Ping, SHAN Liang(*Department of Nephrology, The Second People's Hospital of Hefei, Hefei, Anhui 230000, China)

Keywords

Related Articles

Correlation between serum manganese and non-alcoholic fatty liver disease

Objective To investigate the relationship between serum manganese (Mn) levels and non-alcoholic fatty liver disease (NAFLD) in individuals of different genders. Methods Participants aged 18 years or older from the Nation...

Expert recommendations on the utilization of sodium-glucose cotransporter 2 inhibitors for patients with type 2 diabetes in primary medical institutions

Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are increasingly utilized in the treatment of type 2 diabetes, especially for their efficacy in weight reduction and improvement of cardiovascular and renal outcomes, a...

Predictive value of dynamic assessment of thrombose-related factors in diabetic nephropathy patients for thrombotic risk

"<b>Methods</b> A retrospective study was conducted to select 98 patients with DN who were treated in Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine from January 2020 to September 2022. Follow-u...

Preliminary construction of a prediction model for HBV-related acute-on-chronic liver failure combined with acute kidney injury

<b>Objective</b> To establish a model that can predict the occurrence of acute kidney injury (AKI) in elderly patients with HBV-related acute-on-chronic liver failure (HBV-ACLF), and to conduct a preliminary evaluation...

Delivery outcome of primipara with vaginal delivery receiving novel pulse perineal protective delivery technique

<b>Objective</b> To explore the application effect of novel pulse perineal protective delivery technique in primipara undergoing vaginal delivery. <b>Methods</b> A total of 229 primipara who met the indications for vagin...

Download PDF file
  • EP ID EP743099
  • DOI 10.13429/j.cnki.cjcr.2024.08.016
  • Views 12
  • Downloads 0

How To Cite

MA Tingting*, LIU Li, XU Ping, SHAN Liang(*Department of Nephrology, The Second People's Hospital of Hefei, Hefei, Anhui 230000, China) (2024). Effects of daglipzin on renal function and miR-21-5p and miR-423-5p levels in patients with diabetic nephropathy. Chinese Journal of Clinical Research, 37(8), -. https://europub.co.uk/articles/-A-743099